腹腔镜预测晚期卵巢癌初次肿瘤细胞减灭术结果:一项随机对照试验
这项多中心随机对照试验在荷兰8个妇科肿瘤中心纳入201例疑似晚期卵巢癌且适合初次肿瘤细胞减灭术的患者,随机分入腹腔镜组(102例)或初次手术组(99例)。腹腔镜组无效剖腹术(残留病灶>1 cm)发生10%(10/102),初次手术组为39%(39/99),相对风险0.25(95%CI 0.13-0.47,P<.001)。结论认为诊断性腹腔镜减少了无效剖腹术。
要点
- 腹腔镜组无效剖腹术10%(10/102)vs 初次手术组39%(39/99),相对风险0.25(95%CI 0.13-0.47,P<.001)
- 腹腔镜组62%(63/102)行初次肿瘤细胞减灭术,初次手术组94%(93/99)
- 腹腔镜组3%(3/102)既行初次手术又行间歇性手术,初次手术组28%(28/99),P<.001
核心结论
- 诊断性腹腔镜减少了疑似晚期卵巢癌患者的无效剖腹术。
- 作者认为,对于计划行初次肿瘤细胞减灭术的女性,先行诊断性腹腔镜是合理的;若肿瘤细胞减灭至残留病灶<1 cm看似可行,则继续行初次肿瘤细胞减灭术。
研究设计与样本
- 多中心随机对照试验,在荷兰8个妇科肿瘤中心开展。
- 纳入疑似晚期卵巢癌且符合初次肿瘤细胞减灭术条件的患者,随机分入腹腔镜组或初次手术组。
- 腹腔镜用于指导初始治疗选择:直接初次手术或新辅助化疗后间歇性手术。
- 主要结局为无效剖腹术,定义为初次肿瘤细胞减灭术后残留病灶>1 cm。
- 主要分析按意向性治疗原则进行;2011年5月至2015年2月共纳入201例,腹腔镜组102例,初次手术组99例。
主要发现
- 腹腔镜组63/102(62%)行初次肿瘤细胞减灭术,初次手术组93/99(94%)。
- 无效剖腹术在腹腔镜组为10/102(10%),在初次手术组为39/99(39%),相对风险0.25(95%CI 0.13-0.47,P<.001)。
- 腹腔镜组3/102(3%)同时行初次手术和间歇性手术,初次手术组28/99(28%),P<.001。
临床怎么用
- 作者认为,对于计划行初次肿瘤细胞减灭术的女性,先行诊断性腹腔镜是合理的。
- 作者认为,若腹腔镜评估显示肿瘤细胞减灭至残留病灶<1 cm看似可行,则继续行初次肿瘤细胞减灭术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose To investigate whether initial diagnostic laparoscopy can prevent futile primary cytoreductive surgery (PCS) by identifying patients with advanced-stage ovarian cancer in whom > 1 cm of residual disease will be left after PCS. Patients and Methods This multicenter, randomized controlled trial was undertaken within eight gynecologic cancer centers in the Netherlands. Patients with suspected advanced-stage ovarian cancer who qualified for PCS were eligible. Participating patients were randomly assigned to either laparoscopy or PCS. Laparoscopy was used to guide selection of primary treatment: either primary surgery or neoadjuvant chemotherapy followed by interval surgery. The primary outcome was futile laparotomy, defined as a PCS with residual disease of > 1 cm. Primary analyses were performed according to the intention-to-treat principle. Results Between May 2011 and February 2015, 201 participants were included, of whom 102 were assigned to diagnostic laparoscopy and 99 to primary surgery. In the laparoscopy group, 63 (62%) of 102 patients underwent PCS versus 93 (94%) of 99 patients in the primary surgery group. Futile laparotomy occurred in 10 (10%) of 102 patients in the laparoscopy group versus 39 (39%) of 99 patients in the primary surgery group (relative risk, 0.25; 95% CI, 0.13 to 0.47; P < .001). In the laparoscopy group, three (3%) of 102 patients underwent both primary and interval surgery compared with 28 (28%) of 99 patients in the primary surgery group ( P < .001). Conclusion Diagnostic laparoscopy reduced the number of futile laparotomies in patients with suspected advanced-stage ovarian cancer. In women with a plan for PCS, these data suggest that performance of diagnostic laparoscopy first is reasonable and that if cytoreduction to < 1 cm of residual disease seems feasible, to proceed with PCS.
引用
- Rutten MJ, van Meurs HS, van de Vrie R, et al. Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial. J Clin Oncol. 2016. PMID: 28029317. doi:10.1200/JCO.2016.69.2962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。